Page 16 - Two Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article SPRING HOUSE, Pa., March 16, 2021 /PRNewswire/ --  The Janssen Pharmaceutical Companies of Johnson & Johnson today announced long-term data from the Phase 3 DISCOVER-2 a study showing that the skin clearance, joint symptom relief, and safety of TREMFYA ® (guselkumab) previously demonstrated through 24 weeks and one year (Week 52) in adults with active psoriatic arthritis (PsA) continued through two years (Week 112). 1,2 These findings also confirmed that the robust efficacy TREMFYA demonstrated in patients at Week 24 on physical function, physical aspects of health-relate...

Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI 98% of Treatment-Naïve Patients Achieved and Maintained Undetectable Viral Load with Biktarvy Through Four Years in the Open-Label Extension Phase of Two Phase 3 Studies – – Treatment-Naïve Adults Reached and Maintained Undetectable Viral Load with Biktarvy for Certain Transmitted-Drug Resistance and with No Treatment-Emergent Resistance Through 144 Weeks – Gilead Sciences, Inc. today announced new, … >98% of Treatment-Naïve Patients Achieved and Mainta...

Search jobs U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review Application for Orally Administered Selective P2X3 Receptor Antagonist Based on Findings from Two Phase 3 Trials in Patients with Refractory or Unexplained Chronic Cough Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for gefapixant, an investigational, orally administered, selective P2X3 receptor antagonist, for the treatment of refrac...

The Fantastic Four is one of Marvel's most beloved superhero groups. Many fans hope they can one day become as mainstream as the Avengers.

German police. he asked the loan and there's no indication of islamic extremist motive, but investigators are looking into what they call all possibilities in that crash. >> coming up, facebook founder mark zuckerberg two-phase members this week. they may be ready to underfund him over breaches of personal information. we'll talk to house committee members who are ready to ask very tough russians. our panel debates president trump's high-stakes standoff with china. and what it means for millions of workers, particularly in that state. brand-new details about the horrific bus crash that has can...